REG - GlaxoSmithKline PLC - Result of AGM & GM
GlaxoSmithKline plc
Result of Annual General Meeting and General Meeting
GlaxoSmithKline plc ('GSK') announces that at its Annual General Meeting ('AGM') and General Meeting today, all resolutions were passed by shareholders. The full text of the resolutions considered are contained in the 2019 Notice of AGM and the sole resolution of the General Meeting is contained in the Circular to Shareholders and Notice of General Meeting. These documents are available on the GSK website at www.gsk.com.
GSK AGM Poll Results
The following table shows the total number of votes cast for each resolution:
Resolution
Total votes for*
%
Total votes against
%
Total votes cast
Votes withheld**
1
Receive and adopt the 2018 Annual Report
3,556,826,649
99.95
1,863,433
0.05
3,558,690,082
7,283,024
2
Approve the Annual report on remuneration
3,157,857,593
88.77
399,443,579
11.23
3,557,301,172
8,672,905
3
Election of Iain Mackay
3,509,580,387
98.56
51,394,236
1.44
3,560,974,623
4,999,291
4
Re-election of Philip Hampton
3,523,220,874
98.94
37,814,132
1.06
3,561,035,006
4,939,054
5
Re-election of Emma Walmsley
3,543,610,930
99.50
17,645,007
0.50
3,561,255,937
4,724,016
6
Re-election of Vindi Banga
3,520,241,639
98.87
40,257,748
1.13
3,560,499,387
5,474,256
7
Re-election of Dr Hal Barron
3,542,101,484
99.46
19,107,976
0.54
3,561,209,460
4,763,464
8
Re-election of Dr Vivienne Cox
3,494,225,537
98.85
40,751,267
1.15
3,534,976,804
30,997,813
9
Re-election of Lynn Elsenhans
3,543,230,972
99.50
17,848,986
0.50
3,561,079,958
4,893,685
10
Election of Dr Laurie Glimcher
3,543,924,853
99.52
17,255,115
0.48
3,561,179,968
4,793,241
11
Re-election of Dr Jesse Goodman
3,543,465,739
99.50
17,643,172
0.50
3,561,108,911
4,864,732
12
Re-election of Judy Lewent
3,513,131,684
98.66
47,693,254
1.34
3,560,824,938
5,154,954
13
Re-election of Urs Rohner
3,434,585,693
96.46
126,031,133
3.54
3,560,616,826
5,356,667
14
Re-appointment the auditor
3,557,236,743
99.88
4,327,420
0.12
3,561,564,163
4,412,192
15
Remuneration of auditor
3,554,992,184
99.83
6,020,952
0.17
3,561,013,136
4,948,179
16
Authority for the company to make donations to political organisations and incur political expenditure
3,471,514,277
98.00
70,681,915
2.00
3,542,196,192
23,791,786
17
Authority to allot shares
3,444,525,603
96.77
114,953,481
3.23
3,559,479,084
6,482,169
18
Disapplication of pre-emption rights - general power***
3,480,629,187
97.84
76,741,126
2.16
3,557,370,313
8,607,071
19
Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment***
3,390,801,857
95.31
166,798,143
4.69
3,557,600,000
8,370,163
20
Authority for the company to purchase its own shares***
3,509,141,893
98.57
50,794,321
1.43
3,559,936,214
6,028,543
21
Exemption from statement of senior statutory auditor's name
3,524,087,916
99.51
17,395,554
0.49
3,541,483,470
24,488,266
22
Authority for reduced notice of a general meeting other than an AGM***
3,271,677,728
92.38
269,908,346
7.62
3,541,586,074
24,387,840
GSK General Meeting Poll Results
The following table shows the total number of votes cast for the resolution:
Resolution
Total votes for*
%
Total votes against
%
Total votes cast
Votes withheld**
1
To approve the transaction between GlaxoSmithKline plc, GlaxoSmithKline Consumer Healthcare Holdings Limited and Pfizer, Inc for the purposes of Chapter 11 of the Listing Rules of the Financial Conduct Authority
3,496,633,023
99.85
5,302,329
0.15
3,501,935,352
24,272,073
Notes:
*
Includes discretionary votes. In line with the notification issued to American Depositary Receipt (ADR) holders earlier this year, GSK did not instruct its ADR Depositary to vote any unvoted ADRs in respect of the resolutions for the 2019 AGM and GM
**
A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
***
Indicates Special Resolutions requiring a 75% majority.
The above poll results will shortly be available on the Company's website at www.gsk.com. In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at www.morningstar.co.uk/uk/NSM
Simon Dingemans did not stand for re-election as a Director and retired from the Board with effect from the conclusion of the AGM.
In accordance with section 430(2B) of the Companies Act 2006, GSK confirms that Simon Dingemans will receive payment of fees for service whilst a Director, but no other remuneration payment or payment for loss of office will be made in connection with his departure.
The following table provides further relevant information:
GSK's
Nineteenth
AGM
(2019)
GSK's
Eighteenth
AGM
(2018)
Issued share capital (excluding Treasury Shares)
4,987,806,108
4,959,302,644
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)
71.49%
78.76%
Total shareholder population
108,698
112,326
Total number of proxies lodged
6,635
6,931
% of shareholders who lodged proxies
6.10%
6.17%
Number of shareholders, corporate representatives and proxies who attended the AGM
241
415
V A Whyte
Company Secretary
8 May 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRAGUGUMGAUPBGMR
Recent news on GSK
See all newsREG-GSK Plc: Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Transaction in Own Shares
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Transaction in Own Shares
Announcement